New product intros [brolucizumab, elexacaftor/tezacaftor/ivacaftor (new combination), fedratinib hydrochloride, glucagon (new formulation), pretomanid, rifamycin (new indication/new formulation), ropeginterferon alfa-2b, roxadustat (first-in-class), STR-01, treosulfan (new indication)]

2019 ◽  
Vol 55 (11) ◽  
pp. 719
Sign in / Sign up

Export Citation Format

Share Document